CN1947721A - 表阿霉素缓释制剂的制备方法 - Google Patents
表阿霉素缓释制剂的制备方法 Download PDFInfo
- Publication number
- CN1947721A CN1947721A CNA2006101221859A CN200610122185A CN1947721A CN 1947721 A CN1947721 A CN 1947721A CN A2006101221859 A CNA2006101221859 A CN A2006101221859A CN 200610122185 A CN200610122185 A CN 200610122185A CN 1947721 A CN1947721 A CN 1947721A
- Authority
- CN
- China
- Prior art keywords
- epirubicin
- solution
- slow
- preparation
- polylactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 title claims abstract description 41
- 229960001904 epirubicin Drugs 0.000 title claims abstract description 41
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 title claims description 40
- 238000000034 method Methods 0.000 title description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000004626 polylactic acid Substances 0.000 claims abstract description 22
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 21
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 7
- 238000000502 dialysis Methods 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 2
- MWWSFMDVAYGXBV-FGBSZODSSA-N (7s,9s)-7-[(2r,4s,5r,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydron;chloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-FGBSZODSSA-N 0.000 abstract 1
- 239000011806 microball Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 37
- 239000004005 microsphere Substances 0.000 description 26
- 239000003814 drug Substances 0.000 description 16
- 238000009826 distribution Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000002245 particle Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000000935 solvent evaporation Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 206010048610 Cardiotoxicity Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 231100000259 cardiotoxicity Toxicity 0.000 description 2
- 230000007681 cardiovascular toxicity Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- 229930195573 Amycin Natural products 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 body Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Biological Depolymerization Polymers (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101221859A CN1947721B (zh) | 2006-09-18 | 2006-09-18 | 表阿霉素缓释制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101221859A CN1947721B (zh) | 2006-09-18 | 2006-09-18 | 表阿霉素缓释制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1947721A true CN1947721A (zh) | 2007-04-18 |
CN1947721B CN1947721B (zh) | 2011-01-26 |
Family
ID=38017409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101221859A Active CN1947721B (zh) | 2006-09-18 | 2006-09-18 | 表阿霉素缓释制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1947721B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102209531B (zh) * | 2008-11-14 | 2014-08-27 | 梨花女子大学校产学协力团 | 高分子微球的制造方法和通过该方法制造的高分子微球 |
CN108434124A (zh) * | 2018-06-15 | 2018-08-24 | 厦门大学 | 一种表阿霉素ves复合物和制备方法及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1277465A1 (en) * | 2000-04-24 | 2003-01-22 | Tanabe Seiyaku Co., Ltd. | Process for producing microsphere |
CN1582934A (zh) * | 2004-06-14 | 2005-02-23 | 王安训 | 喜树碱衍生物的纳米微粒、制备方法及其药物用途 |
CN100400032C (zh) * | 2004-09-16 | 2008-07-09 | 同济大学 | 一种油溶性药物缓释微球的制备方法 |
-
2006
- 2006-09-18 CN CN2006101221859A patent/CN1947721B/zh active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102209531B (zh) * | 2008-11-14 | 2014-08-27 | 梨花女子大学校产学协力团 | 高分子微球的制造方法和通过该方法制造的高分子微球 |
CN108434124A (zh) * | 2018-06-15 | 2018-08-24 | 厦门大学 | 一种表阿霉素ves复合物和制备方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1947721B (zh) | 2011-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zupančič | Core-shell nanofibers as drug-delivery systems | |
Abdul Hameed et al. | Electrospun nanofibers for drug delivery applications: Methods and mechanism | |
US7883723B2 (en) | Water soluble chitosan nanoparticle for delivering an anticancer agent and preparing method thereof | |
Vijayan et al. | Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: In vitro and in vivo studies | |
KR101862416B1 (ko) | 마이크로입자를 제조하기 위한 에멀전-기반 방법 및 이 방법과 함께 사용하기 위한 워크헤드 조립체 | |
EP2644191B1 (en) | Nonwoven membrane as a drug delivery system | |
US20100003300A1 (en) | Injectable delivery of microparticles and compositions therefore | |
CN104136012B (zh) | 制备装载有活性物质的纳米颗粒的方法 | |
Shah et al. | Chitosan and carboxymethyl cellulose-based 3D multifunctional bioactive hydrogels loaded with nano-curcumin for synergistic diabetic wound repair | |
Dhanka et al. | Injectable methotrexate loaded polycaprolactone microspheres: physicochemical characterization, biocompatibility, and hemocompatibility evaluation | |
Meng et al. | Tenofovir containing thiolated chitosan core/shell nanofibers: in vitro and in vivo evaluations | |
JP2007070332A (ja) | 多糖類で機能化された水和ゲル膜を有するナノ粒子とこれを含む徐放型薬物伝達システム及びその製造方法 | |
Norouzi et al. | Emulsion electrospinning of sodium alginate/poly (ε-caprolactone) core/shell nanofibers for biomedical applications | |
Stevanović et al. | ROS-inducing potential, influence of different porogens and in vitro degradation of poly (D, L-lactide-co-glycolide)-based material | |
Priya Dasan et al. | Polymer blend microspheres for controlled drug release: the techniques for preparation and characterization: a review article | |
Liu et al. | Biodegradable and dissolvable resveratrol nanocrystals non-silicon microneedles for transdermal drug delivery | |
CN1947721B (zh) | 表阿霉素缓释制剂的制备方法 | |
Ebhodaghe | A scoping review on the biomedical applications of polymeric particles | |
Joung et al. | PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs | |
Zhao et al. | Development and optimization of insulin-chitosan nanoparticles | |
Lee et al. | Thiolate poly (lactic-co-glycolic acid) nanofibers loaded with dexamethasone and ropivacaine show enhanced sustained release in the treatment of neuropathic pain through a local therapy technique | |
CN115920126A (zh) | 负载植物外泌体的聚羟基脂肪酸酯微球及其制备方法 | |
CN114748637B (zh) | 苯硼酸修饰型纳晶药物稳定系统及其制备方法和应用 | |
Ahmady et al. | Alginate carrier as a controlled thymol delivery system: Effect of particle size | |
EP2552412A2 (en) | Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HISUN HUIRUI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: XIAMEN UNIVERSITY Effective date: 20140917 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 361005 XIAMEN, FUJIAN PROVINCE TO: 200032 XUHUI, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140917 Address after: 200032, room 10, building 596, block A, No. 1003 middle Longhua Road, Shanghai, Xuhui District Patentee after: HAIZHENGHUI PHARMACEUTICAL CO., LTD. Address before: Xiamen City, Fujian Province, 361005 South Siming Road No. 422 Patentee before: Xiamen University |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: HAIZHENGHUI PHARMACEUTICAL CO., LTD. Document name: Notification of Passing Examination on Formalities |
|
CP03 | Change of name, title or address |
Address after: 311404 2 Hai Zheng Road, Xu Kou Town, Fuyang District, Hangzhou, Zhejiang Patentee after: Hanhui Pharmaceutical Co., Ltd. Address before: Room 1003, 10th floor, Block A, 596 Longhuazhong Road, Xuhui District, Shanghai Patentee before: HAIZHENGHUI PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |